Saudi Arabia Wound Care Market: Clinical Innovation, Aging Population & Growth Forecast

The demand for better wound management is accelerating across Saudi Arabia, driven by a surge in chronic health conditions, significant government investment in healthcare infrastructure, and a rapid uptake of advanced medical technologies. According to IMARC Group's latest research, the Saudi Arabia wound care market was worth USD 0.22 Billion in 2024. Looking ahead, the market is projected to reach USD 0.32 Billion by 2033, growing at a CAGR of 4.35% from 2025 to 2033.

Wound care has become a critical health priority in the Kingdom. With more people living longer and chronic diseases like diabetes on the rise, there's an urgent need for products that go beyond basic bandages. Healthcare providers are now turning to advanced dressings, negative pressure wound therapy systems, and antimicrobial solutions that speed up healing, cut down on infections, and improve patient quality of life. The sector is also seeing a shift toward home-based care, making wound management more accessible and reducing the strain on hospitals. These changes are reshaping the landscape and opening doors for innovative solutions that meet real-world medical needs.

Get a Sample Report for Actionable Market Insights

Saudi Arabia Wound Care Market Growth Drivers:

• Rising Prevalence of Chronic Diseases

Diabetes has become a major health concern in Saudi Arabia, affecting roughly 17.7% of adults nationwide. This puts the Kingdom among the highest globally for diabetes prevalence and directly drives demand for specialized wound care. Diabetic foot ulcers, pressure sores, and other chronic wounds are becoming more common, requiring advanced treatments like foam dressings, hydrocolloids, and hydrogels. These products don't just cover wounds—they create optimal healing environments, minimize infection risk, and support faster recovery. Healthcare facilities are prioritizing these solutions to improve patient outcomes and reduce long-term complications associated with chronic conditions.

• Expanding Healthcare Infrastructure and Government Investment

Vision 2030 is transforming healthcare delivery across the Kingdom. In May 2024, the Saudi government earmarked USD 65 billion to upgrade healthcare infrastructure, train local medical professionals, restructure health services, and establish 21 health clusters throughout the country. This massive investment is modernizing hospitals and clinics, equipping them with state-of-the-art wound care technologies. New facilities are adopting negative pressure wound therapy, bioelectric smart bandages, and digital wound monitoring systems. The push toward privatization and public-private partnerships is also accelerating innovation, bringing international expertise and cutting-edge solutions to the Saudi market.

• Growing Demand for Home-Based Wound Care

Saudi Arabia's aging population is reshaping healthcare delivery. Research shows that the ratio of people over 65 to those aged 20–64 is expected to nearly double between 2020 and 2030. This demographic shift is fueling demand for convenient, at-home wound care options. Patients and caregivers want user-friendly dressings, antiseptics, and self-application devices that allow effective wound management without constant hospital visits. Telemedicine platforms and home healthcare services are making this possible, supporting the Vision 2030 goal of patient-centric care. This trend is particularly strong in remote areas where access to specialized medical facilities is limited.

Saudi Arabia Wound Care Market Trends:

• Rapid Adoption of Advanced Wound Care Technologies

Saudi hospitals and clinics are moving away from traditional gauze and tape toward sophisticated solutions. Negative pressure wound therapy systems, antimicrobial dressings with silver ions, bioactive skin substitutes, and smart monitoring devices are gaining traction. These technologies deliver measurable improvements—faster healing, reduced infection rates, and better patient comfort. For complex cases like diabetic foot ulcers or post-surgical wounds, healthcare providers are increasingly relying on these advanced products. Machine learning tools are even being tested in specialty foot clinics to classify wound severity and recommend optimal treatment protocols, streamlining care delivery and inventory management.

• Localization Through 'Made in Saudi' Manufacturing Initiatives

The Kingdom is pushing hard to build domestic manufacturing capacity for medical devices. In March 2025, Mölnlycke Health Care expanded its stake in Tamer Mölnlycke Care from 33.3% to 60%, strengthening local production and distribution capabilities. International players are setting up joint ventures and assembly operations to meet localization quotas while maintaining quality standards. These partnerships are shortening supply chains, reducing import costs, and creating jobs for Saudi nationals. The government's support through incentives and streamlined regulations is making it easier for both multinational companies and emerging local firms to establish manufacturing facilities in industrial cities like Riyadh and Jeddah.

• Increasing Focus on Specialty Wound Care Clinics

Specialized wound care centers are emerging as referral hubs for difficult cases. These facilities bring together trained wound care specialists, advanced diagnostic equipment, and comprehensive treatment protocols under one roof. Patients with chronic wounds that aren't responding to standard care are being directed to these centers, where multidisciplinary teams can provide targeted interventions. Insurance coverage for these specialized services is expanding, making them more accessible. The centers are also serving as training grounds for healthcare professionals, helping to build expertise in advanced wound management techniques and establishing best practices across the Kingdom's healthcare system.

Recent News and Developments in Saudi Arabia Wound Care Market

• May 2024: TVM Capital Healthcare closed its Saudi-focused TVM Healthcare Afiyah Fund, raising approximately USD 250 million to support healthcare advancements aligned with Vision 2030. Among the fund's initial investments, DEBx Medical, a Dutch company specializing in innovative chronic wound care products, announced plans to enter the Saudi market. This move brings advanced enzymatic debridement solutions and chronic wound treatments to enhance the Kingdom's healthcare infrastructure and improve patient outcomes across the region.
• August 2024: STADA, a leading pharmaceutical company, announced the strategic acquisition of FITO™ from LEO Pharma to expand its consumer healthcare business in the Middle East. This medical device, which uses wheat extract Rigenase, is indicated for treating wounds, first- and second-degree burns, ulcers, and abrasions. The acquisition strengthens STADA's presence in Saudi Arabia and brings additional wound care options to healthcare providers and patients throughout the Kingdom.
• September 2024: Oxybarica, a leader in hyperbaric oxygen therapy, announced plans to expand its footprint in the Middle East, including Saudi Arabia, to meet growing demand for advanced wound care and therapeutic solutions. The expansion aims to enhance healthcare standards through hyperbaric oxygen therapy and foster collaboration with regional providers to improve patient outcomes, particularly for chronic wounds and post-surgical recovery cases.
• November 2024: Bonvadis topical cream received Medical Device Marketing Authorization approval for all wound indications across Saudi Arabia. Additionally, DEBx Medical successfully concluded its second round of capital investment, led by TVM Capital Healthcare, to accelerate commercialization of DEBRICHEM® and expand access to innovative chronic wound care solutions for patients across the Kingdom and wider MENA region.
• March 2025: Mölnlycke Health Care expanded its stake in Tamer Mölnlycke Care from 33.3% to 60%, becoming the majority shareholder. This increased investment enables expansion of the product range manufactured and distributed in the country, including drapes, gowns, emollients, and selected wound care products. The joint venture's factory is set to commence production of customized surgical procedure trays, strengthening local manufacturing capabilities and improving access to quality wound care solutions.
• March 2025: AMS BioteQ signed a Memorandum of Understanding with four Middle East distributors to launch its SIPSIP® wound care series in Saudi Arabia, with sales slated to begin in the second half of 2025. The SIPSIP® series utilizes moist wound healing therapy with excellent absorbency and anti-adhesive properties, addressing the market gap for effective chronic wound infection solutions.
• April 2025: A leading healthcare provider in Saudi Arabia announced the implementation of a new advanced wound care program across its hospitals, aiming to enhance treatment of chronic wounds through adoption of innovative therapies and technologies. Additionally, King Faisal Specialist Hospital and Research Center employed an advanced arterial stent technique using bioresorbable stents to restore blood circulation, accelerate wound healing, and decrease the likelihood of amputation in complex cases.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.